ACM
TMO icon

Accent Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Accent Capital Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$38.8K Buy
79
+54
+216% +$29.3K 0.02% 120
2025
Q4 		$14.5K Hold
25
– – 0.01% 162
2025
Q3 		$12.1K Sell
25
-916
-97% -$426K 0.01% 189
2025
Q2 		$382K Buy
941
+25
+3% +$10.5K 0.17% 51
2025
Q1 		$456K Buy
916
+62
+7% +$33.6K 0.26% 41
2024
Q4 		$445K Hold
854
– – 0.25% 41
2024
Q3 		$529K Sell
854
-721
-46% -$427K 0.3% 38
2024
Q2 		$871K Buy
+1,575
New +$902K 0.53% 27
2024
Q1 		– Sell
-1,575
Closed -$836K – 191
2023
Q4 		$836K Buy
+1,575
New +$762K 0.66% 27

Other funds holding TMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Accent Capital Management's TMO Position: Q1 2026 in Review

Accent Capital Management increased its Thermo Fisher Scientific (TMO) stake by 216% in Q1 2026, buying an estimated $29.3K and bringing the position to 79 shares worth $38.8K. The position accounts for 0.02% of the portfolio, ranked #120.

Accent Capital Management first reported a position in TMO in Q4 2023 and has held it in 9 quarters since. The position peaked at $871K in Q2 2024. 2,588 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Accent Capital Management held 79 shares of Thermo Fisher Scientific worth $38.8K as of Q1 2026.
  • Accent Capital Management bought 54 Thermo Fisher Scientific shares in Q1 2026, an estimated $29.3K.
  • Thermo Fisher Scientific made up 0.02% of Accent Capital Management's portfolio in Q1 2026, its #120 holding.
  • Accent Capital Management first reported a position in Thermo Fisher Scientific in Q4 2023 and has held it in 9 quarters since.
  • Accent Capital Management's Thermo Fisher Scientific position peaked at $871K in Q2 2024.
  • 2,588 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Accent Capital Management's 13F filing for Q1 2026, filed 11 May 2026.